Logo image
Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma
Journal article   Open access   Peer reviewed

Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma

Pamela Norton, Mary Ann Comunale, Harmin Herrera, Mengjun Wang, Josef Houser, Michaela Wimmerova, Patrick R Romano and Anand Mehta
Proteomics (Weinheim), v 16(24), pp 3126-3136
Dec 2016
PMID: 27650323
url
https://europepmc.org/articles/pmc5869706View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Ascomycota - chemistry Biomarkers, Tumor - analysis Biomarkers, Tumor - metabolism Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - metabolism Cell Line Cells, Cultured Fucose - analysis Fucose - metabolism Glycoproteins - analysis Glycoproteins - metabolism Hepatocytes - metabolism Hepatocytes - pathology Humans Lectins - chemistry Lectins - metabolism Liver - metabolism Liver - pathology Liver Neoplasms - diagnosis Liver Neoplasms - metabolism Polysaccharides - chemistry Polysaccharides - metabolism Protein Binding Proteomics Recombinant Proteins - chemistry Recombinant Proteins - metabolism
The Aleuria aurantia lectin (AAL) derived from orange peel fungus contains five fucose-binding sites that recognizes fucose bound in α-1,2, α-1,3, α-1,4, and α-1,6 linkages to N-acetylglucosamine and galactose. Recently, we have created several recombinant AAL (rAAL) proteins that had altered binding affinity to fucose linkages. In this report, we further characterize the binding specificity of one of the mutated lectins, N224Q lectin. This lectin was characterized by lectin Western blotting, surface plasmon resonance, and glycan microarray and shown to have increased binding to fucosylated glycan. Subsequently, we used this lectin to identify secreted fucosylated glycoproteins from a fetal hepatic cell line. Proteomic analysis revealed several glycoproteins secreted by the fetal cell line that were bound by N224Q lectin. These findings were confirmed by subsequent proteomic analysis of human serum from control patients or patients with hepatocellular carcinoma. These represent candidate oncofetal markers for liver cancer.

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Biochemical Research Methods
Biochemistry & Molecular Biology
Logo image